| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/25/1996 | US5529765 Rabbit model for diagnosing and testing vaccines or therapeutic agents against aids |
| 06/25/1996 | US5529756 Apparatus and method for polymer synthesis using arrays |
| 06/24/1996 | CA2163159A1 Penicillin v amidohydrolase gene from fusarium oxysporum |
| 06/20/1996 | WO1996018905A1 A method for preparing non-proteinaceous strongly negatively charged macrobiomolecules, which are linked to plastic |
| 06/20/1996 | WO1996018745A1 Conserved yeast nucleic acid sequences |
| 06/20/1996 | WO1996018744A2 Dna purification by forming a triple helix with an immobilized oligonucleotide |
| 06/20/1996 | WO1996018741A2 Liposome-mediated transfection of central nervous system cells |
| 06/20/1996 | WO1996018740A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 06/20/1996 | WO1996018739A1 Plant adenylosuccinate lyase and dna coding therefor |
| 06/20/1996 | WO1996018738A2 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES |
| 06/20/1996 | WO1996018737A2 Vectors and viruses for use in gene therapy |
| 06/20/1996 | WO1996018736A2 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses |
| 06/20/1996 | WO1996018735A2 Tgf-beta superfamily type ii receptor having binding affinity for bone morphogenic protein (bmp) |
| 06/20/1996 | WO1996018734A1 Production of recombinant secretory component |
| 06/20/1996 | WO1996018733A2 Ribozyme-mediated inactivation of leukemia-associated rna |
| 06/20/1996 | WO1996018732A2 Sequence-specific inhibition of dna synthesis by triplex-forming oligonucleotides |
| 06/20/1996 | WO1996018731A2 Isolation of nucleic acid |
| 06/20/1996 | WO1996018730A1 Prostatic growth factor |
| 06/20/1996 | WO1996018728A1 Chondrocyte cell-lines |
| 06/20/1996 | WO1996018727A1 Adeno-associated derived vector systems for gene delivery and integration into target cells |
| 06/20/1996 | WO1996018725A1 Human tissue inhibitor of metalloproteinase-4 |
| 06/20/1996 | WO1996018722A2 Process for obtaining improved strains of trichoderma spp. |
| 06/20/1996 | WO1996018654A1 Factor vii fragment 82-128 and its use in blood-clotting disorders |
| 06/20/1996 | WO1996018651A1 Human somatostatin-like receptor |
| 06/20/1996 | WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection |
| 06/20/1996 | WO1996018641A1 Modulators of the function of fas/apo1 receptors |
| 06/20/1996 | WO1996018640A1 Antisense nucleic acid homolog |
| 06/20/1996 | WO1996018639A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
| 06/20/1996 | WO1996018418A1 Improved adenoviral vectors and producer cells |
| 06/20/1996 | WO1996018416A1 Expression inhibitor against human interleukin-6 receptor |
| 06/20/1996 | WO1996018414A1 Acellular anti-bordetella vaccine |
| 06/20/1996 | WO1996018412A1 Chimeric cytokines and uses thereof |
| 06/20/1996 | WO1996018409A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | WO1996018390A1 Delivery of nucleic acid molecules to mucosal tissue |
| 06/20/1996 | WO1996018372A2 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 06/20/1996 | WO1996018303A1 Myoblast therapy for mammalian diseases |
| 06/20/1996 | WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 06/20/1996 | WO1996012397A3 Recombinant antibody capable of binding to pna/nucleic acid complexes |
| 06/20/1996 | WO1996012018A3 Novel immunophilins and corresponding nucleic acids |
| 06/20/1996 | CA2208224A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 06/20/1996 | CA2207816A1 Conserved yeast nucleic acid sequences |
| 06/20/1996 | CA2207764A1 Chondrocyte cell-lines |
| 06/20/1996 | CA2207736A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | CA2207626A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | CA2207593A1 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses |
| 06/20/1996 | CA2207581A1 Probin tyrosine kinase (pyk2) its cdna cloning and its uses |
| 06/20/1996 | CA2206683A1 Improved adenoviral vectors and producer cells |
| 06/20/1996 | CA2206669A1 Human tissue inhibitor of metalloproteinase-4 |
| 06/20/1996 | CA2206244A1 Adeno-associated derived vector systems for gene delivery and integration into target cells |
| 06/20/1996 | CA2205572A1 Chimeric cytokines and uses thereof |
| 06/20/1996 | CA2205418A1 Plant adenylosuccinate lyase and dna coding therefor |
| 06/20/1996 | CA2183167A1 Myoblast therapy for mammalian diseases |
| 06/20/1996 | CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling |
| 06/19/1996 | EP0717110A1 LGMD gene |
| 06/19/1996 | EP0717109A1 Synthetic DNA derived recombinant HIV-2 antigens |
| 06/19/1996 | EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 06/19/1996 | EP0717107A1 Transformant line of candida utilis yeast and expression of heterogene therewith |
| 06/19/1996 | EP0717106A1 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
| 06/19/1996 | EP0717105A2 Genomic DNA fragments cooling for the beta2-subunit of the neuronal nicotinic acetylcholine receptor; transgenic animals containing it |
| 06/19/1996 | EP0716808A2 Use of Auxin-type herbicides for the treatment of transgenic crops |
| 06/19/1996 | EP0716714A1 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(CHLAMYDIA TRACHOMATIS) |
| 06/19/1996 | EP0716713A1 Compositions and methods for detecting target nucleic acid sequences utilizing adjacent sequence-enzyme molecules |
| 06/19/1996 | EP0716711A1 Vector for gene therapy of the liver |
| 06/19/1996 | EP0716710A1 Methods of suppressing immune response by gene therapy |
| 06/19/1996 | EP0716709A1 Enhanced expression in plants using non-translated leader sequences |
| 06/19/1996 | EP0716708A1 Medium chain-specific thioesterases |
| 06/19/1996 | EP0716707A1 Promoters |
| 06/19/1996 | EP0716706A1 Method of production of transgenic plants wholly transformed into t o? generation, from meristems |
| 06/19/1996 | EP0716705A1 Method for the recombinant preparation of proteins in hansenula yeast |
| 06/19/1996 | EP0716704A1 MULTIPLE INTEGRATIVE VECTORS AND $i(YARROWIA LIPOLYTICA) TRANSFORMANTS |
| 06/19/1996 | EP0716702A1 Thermostable xylanases |
| 06/19/1996 | EP0716701A1 Cloning of a member of the serine-threonine-kinase family |
| 06/19/1996 | EP0716700A1 Models of alzheimer's disease |
| 06/19/1996 | EP0716699A1 Glycerin-3-phosphate-dehydrogenase (gpdh) |
| 06/19/1996 | EP0716698A1 Process for the efficient production of 7-ADCA via 2-(carboxyethylthio)acetyl-7-ADCA and 3-(carboxymethylthio)propionyl-7-ADCA |
| 06/19/1996 | EP0716697A1 DIFFERENTIALLY EXPRESSED $i(LEISHMANIA) GENES AND PROTEINS |
| 06/19/1996 | EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 06/19/1996 | EP0716695A1 Human calcium channel compositions and methods using them |
| 06/19/1996 | EP0716694A1 Human glucagon-like 1 peptide receptor |
| 06/19/1996 | EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 06/19/1996 | EP0716692A1 Methods of suppressing autoimmune response |
| 06/19/1996 | EP0716691A1 Methods of suppressing graft rejection |
| 06/19/1996 | EP0716662A1 Dna encoding prostaglandin receptor ep2 |
| 06/19/1996 | EP0716660A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 06/19/1996 | EP0716614A1 Treatment of human tumors by genetic transformation of human tumor cells |
| 06/19/1996 | EP0716604A1 Thiol-derivatized nucleosides and oligonucleosides |
| 06/19/1996 | EP0662143B1 Microorganisms for the production of tryptophan and process for producing the same |
| 06/19/1996 | EP0621899B1 Expression signal-peptide-free staphylokinases |
| 06/19/1996 | EP0578663B1 Method for the isolation and/or testing of genes and promoters involved in plant-nematode interactions using plants of the genus arabidopsis |
| 06/19/1996 | EP0546090B1 Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases |
| 06/19/1996 | EP0527778B1 Improved process of purifying recombinant proteins and compounds useful in such process |
| 06/19/1996 | EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor |
| 06/19/1996 | EP0506923B1 A collagen binding protein as well as its preparation |
| 06/19/1996 | EP0495852B1 Modified biological material |
| 06/19/1996 | EP0452484B1 Production of proteins using homologous recombination |
| 06/19/1996 | EP0424397B1 Calcium channel compositions and methods |
| 06/19/1996 | EP0418310B1 Gene for encoding a human malaria vaccine antigen |
| 06/19/1996 | EP0309550B1 Novel proteolytic enzymes |
| 06/19/1996 | CN1124980A Modified oligonucleotides having improved anti-influenza activity |